Product
Supplier
Encyclopedia
Inquiry
CAS 22503-72-6 IDRA 21 buy - large image1
CAS 22503-72-6 IDRA 21 buy - image1
CAS 22503-72-6 IDRA 21 buy - image2
CAS 22503-72-6 IDRA 21 buy - image3
CAS 22503-72-6 IDRA 21 buy - image4
CAS 22503-72-6 IDRA 21 buy - image5
CAS 22503-72-6 IDRA 21 buy - image6

CAS 22503-72-6 IDRA 21

Unit Price: Get Latest Price
CAS No.:

22503-72-6

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SZ

Brand:

JF

Packaging:

according to your request

Price valid (until):

2025-12-21

Company Type:
Trader
Location:
Hongkong, China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Details

  • Seller Information

  • Description

    Information

    IDRA-21 is a relatively new nootropic compound.   It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.
    IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by  orscopolamine,and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
    IDRA-21 is classified as an ampakine. It is able to improve focus and attention as well as promote learning and memory. Ampakines are growing in popularity largely because they provide the cognitive benefits of stimulants without the undesirable side effects.

    Other Name: IDRA21;IDRA21,7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazineS,S-dioxide;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE1,1-DIOXIDE;7-CHLChemicalbookORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINES,S-DIOXIDE;IDRA21,98%;7-chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine1,1-dioxide;7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine1,1-dioxide


    Shop IDRA 21 CAS 22503-72-6-Detailed Image 1

    Product name IDRA 21
    CAS No. 22503-72-6
    MF C8H9ClN2O2S
    MW 232.69
    Melting point 209 °C(Solv: acetic acid )
    Boiling point 405.1±55.0 °C(Predicted)
    Density 1.394±0.06 g/cm3(Predicted)
    Storage Keep in dark place,Inert atmosphere,Room temperature

    The efficacy of Idra 21
    Idra 21 has a good efficacy in treating hypoglycemia caused by some substence. This condition is commonly seen in inoperable islet cell adenomas in adults, extrapancreatic malignant tumors, and islet cell hyperplasia in infants and children.
    Adult therapeutic applications
    For adult patients, Idra 21 can effectively reduce some substence caused by islet cell adenoma or extrapancreatic malignant tumors, thereby alleviating hypoglycemic symptoms. Its therapeutic effect is rapid and good in most cases, which is helpful to improve the quality of life of patients.
    Applications for children and infant treatment
    In infant and pediatric patients, Idra 21 also shows good therapeutic effects. Especially in the treatment of hypoglycemia caused by leucine-sensitive islet cell hyperplasia and islet blastocytosis, etc., Idra 21 can play an important role, helping children maintain normal blood sugar levels and promoting their healthy growth.
    Idra 21 shows wide applicability in the treatment of hypoglycemia caused by some substence, and its therapeutic effect is stable and good. Whether it is adult or pediatric patients, Idra 21 can provide effective therapeutic support to help patients restore normal blood sugar levels.
    Pharmacological effects of Idra 21
    The pharmacological effect of Idra 21 is mainly reflected in its regulatory effect on the KATP channel. By activating the KATP channel, Idra 21 can affect some substence secretion and the metabolic activities of cells, thereby achieving the regulation of blood glucose levels.
    KATP channel activation
    The KATP channel is a potassium ion channel located on the cell membrane, which has an important influence on the cell's metabolism and some substence secretion. Idra 21 can bind to KATP channels and activate their opening, thereby promoting the efflux of potassium ions. This effect helps to reduce the excitability of pancreatic islet β cells and decrease some substence secretion.
    Shop IDRA 21 CAS 22503-72-6-Detailed Image 2
    Shop IDRA 21 CAS 22503-72-6-Detailed Image 3 Shop IDRA 21 CAS 22503-72-6-Detailed Image 4 Shop IDRA 21 CAS 22503-72-6-Detailed Image 5 Shop IDRA 21 CAS 22503-72-6-Detailed Image 6

    FAQ

    Q1: Are you the manufacturer or trade company?
    --We are the manufacturer in China, founded on 2011.

    Q2: When will the product be shipped after payment?
    --The parcel will be get ready and shipped within 1 day.

    Q3: How long will it take to receive the parcel?
    --3-5days for the US market; 3-7days for the others.

    Q4: What can I do if I don't have the ability to clear the custom.
    --We got experience after doing export for many years, so don't worry we can handle that.

    Q5: Why should you buy from us not from other suppliers?
    --Medium-sized enterprise integrating the development, production, sales and export and import trade of chemical products. Our factory has perfect infrastructure, advanced processing technology and completed detection means.

    ECHEMI Editorial Reference
    7-chloro-3-methyl-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide is a benzothiadiazine.
    white to off-white crystalline powder

    Basic Info
    Product Name:

    IDRA 21

    Other Name:

    IDRA 21;IDRA 21,7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazineS,S-dioxide;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE S,S-DIOXIDE;IDRA 21,98%;7-chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide;7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide

    CAS No.:

    22503-72-6

    Molecular Formula:

    C8H9ClN2O2S

    InChIKeys:

    VZRNTCHTJRLTMU-UHFFFAOYSA-N

    Molecular Weight:

    232.69

    Exact Mass:

    232.69

    EC Number:

    1592732-453-0

    Color/Form:

    Off-White to Pale Yellow

    Characteristics
    Density:

    1.394±0.06 g/cm3(Predicted)

    Melting Point:

    209 °C(Solv: acetic acid (64-19-7))

    Boiling Point:

    405.1±55.0 °C(Predicted)

    PKA:

    9.78±0.40(Predicted)

    Critical Temperature & Pressure:

    Keep in dark place,Inert atmosphere,Room temperature

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.